Pfizer announces positive results from phase-III study in 20-valent Pneumococcal Conjugate Vaccine in infants in EU Read more
EMA increases general, non-pharmacovigilance fees by 0.3 per cent and 5.3 per cent from 1st April, 2022 Read more
Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion Read more